Futurism logo

Medical Imaging Market Outlook: Diagnostic Innovation and Healthcare Expansion Opportunities

The medical imaging market is experiencing significant growth, driven by increasing demand for early and accurate disease diagnosis, rising prevalence of chronic conditions, and continuous advancements in imaging technologies.

By Michael RichardPublished 13 days ago 6 min read

According to IMARC Group's latest research publication, The global medical imaging market size reached USD 46.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 71.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.78% during 2026-2034.

How AI is Reshaping the Future of Medical Imaging Market

  • Automated Image Analysis and Lesion Detection: AI-powered deep learning algorithms analyze medical scans with exceptional precision, automatically identifying tumors, fractures, and abnormalities that might be missed by human eyes. These systems process thousands of images daily, delivering consistent diagnostic accuracy while significantly reducing radiologists' workload and interpretation time.
  • Predictive Risk Assessment and Early Disease Detection: Machine learning models analyze imaging data combined with patient history to forecast disease development years before symptoms appear. Algorithms can predict breast cancer risk, assess pancreatic cancer likelihood from electronic records alone, and identify cardiovascular risks, enabling preventive interventions that transform healthcare from reactive treatment to proactive care.
  • Workflow Optimization and Radiologist Burnout Reduction: AI streamlines radiology workflows by automating routine tasks, prioritizing urgent cases, and generating preliminary reports automatically. With radiologist burnout reaching 45% due to increasing caseloads, AI-driven triage and automated mundane tasks allow specialists to focus on complex cases and patient consultations rather than repetitive image interpretation.

Explore Updated 2026 Market Trends & Analysis

Medical Imaging Industry Overview:

The medical imaging sector is experiencing transformative growth driven by technological innovation and surging healthcare demands. The United Nations projects the global population aged 60 or above will reach 1.4 billion by 2030, creating unprecedented demand for diagnostic imaging to manage age-related conditions like dementia, cardiovascular disease, and cancer. GE Healthcare leads the market with 72 FDA-cleared AI devices, followed by Siemens Healthineers with 47 clearances and Philips Healthcare with 38 clearances. Siemens Healthineers invested USD 150 million in July 2025 to expand U.S. manufacturing and R&D facilities, while GE Healthcare's Edison platform integrates AI across imaging workflows, and Philips launched the world's first detector-based spectral CT powered entirely by AI.

Medical Imaging Market Trends & Drivers

Chronic disease prevalence is driving explosive demand for advanced imaging technologies as healthcare systems prioritize early detection and continuous monitoring. The World Health Organization reports non-communicable diseases cause 43 million deaths annually, with cardiovascular conditions responsible for 19 million deaths, cancer for 10 million, respiratory diseases for 4 million, and diabetes for over 2 million deaths. Medical imaging plays a critical role in identifying organ abnormalities, tracking disease progression, and guiding treatment decisions across cardiology, oncology, and pulmonology. The emphasis on preventive care is pushing routine screening programs, particularly for high-risk populations requiring periodic monitoring. Hospitals and diagnostic centers are deploying sophisticated imaging systems like Siemens' SOMATOM X.ceed CT scanner, which delivers exceptional resolution and rapid imaging speeds that enhance diagnostic accuracy while improving workflow efficiency for complex conditions including cancer, cardiovascular disease, and musculoskeletal disorders.

Artificial intelligence integration is revolutionizing medical imaging workflows and clinical decision-making across all specialties. The radiology AI market reached USD 760 million and is expanding rapidly as healthcare providers implement automated reporting, anomaly detection, and clinical support systems that accelerate diagnoses and enhance precision. GE Healthcare partnered with NVIDIA at GTC 2025 to advance autonomous imaging solutions, starting with self-sufficient X-ray and ultrasound applications that reduce manual intervention. Philips and Cortechs.ai extended their collaboration to strengthen quantitative neuroimaging and precision diagnostics in neurology, while Hologic received FDA clearance for the Genius Digital Diagnostics System combining deep-learning AI with volumetric imaging to identify pre-cancerous lesions and cervical cancer cells. These AI-driven tools enable radiologists to process larger caseloads with greater accuracy, automatically flag suspicious findings for priority review, and generate preliminary reports that streamline workflows. The UK Biobank completed imaging for 100,000 participants, creating foundational datasets for AI training and validation that will accelerate algorithm development across diverse populations and rare disease scenarios.

Healthcare infrastructure expansion and government initiatives are accelerating medical imaging adoption globally, particularly in emerging markets and underserved regions. Hospitals across Europe, Asia, and Australia announced major equipment upgrades, replacing aging CT, MRI, and PET/CT systems with modern platforms featuring AI capabilities, lower radiation doses, and enhanced patient comfort. Siemens Healthineers partnered with the European Society of Radiology in February 2025 to promote sustainability through resource-efficient imaging, AI-driven diagnostics, reduced energy consumption, and expanded access in underserved areas. Neuberg Diagnostics established a joint venture with Star Imaging in Maharashtra to broaden integrated diagnostic centers combining radiology, pathology, wellness, and genomics under unified frameworks that improve diagnostic accuracy and speed. The Centers for Medicare & Medicaid Services approved reimbursement for 10 AI applications despite over 880 FDA-cleared AI medical devices, creating complex financial landscapes that healthcare providers must navigate when adopting new technologies. These infrastructure investments address rising imaging demands from aging populations, chronic disease burdens, and expanding screening programs while ensuring equitable access regardless of geographic location or socioeconomic status.

Leading Companies Operating in the Global Medical Imaging Industry:

  • Canon Medical Systems Corporation
  • Carestream Health
  • Cubresa Inc.
  • Esaote SpA
  • FUJIFILM Sonosite, Inc.
  • GE HealthCare
  • Hitachi High-Tech Corporation
  • Konica Minolta, Inc.
  • Koninklijke Philips N.V.
  • Samsung Healthcare
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd
  • Siemens Healthineers AG

Medical Imaging Market Report Segmentation:

By Product:

  • CT Scanners
  • X-Ray Imaging Systems
  • MRI Systems
  • Ultrasound Imaging Systems
  • Nuclear Imaging Systems
  • Mammography Systems

X-ray imaging systems account for the majority of the market share as they provide quick, non-invasive diagnostics for detecting fractures, infections, and abnormalities.

By Application:

  • Obstetrics and Gynecology Health
  • Orthopedics and Musculoskeletal
  • Neuro and Spine
  • Cardiovascular and Thoracic
  • General Imaging
  • Breast Health
  • Others

Cardiovascular and thoracic represents the largest segment owing to the heightened occurrence of heart conditions, lung diseases, and vascular abnormalities.

By End User:

  • Hospitals
  • Diagnostic Centers
  • Academic Institutes and Research Organizations

Hospitals hold the largest market share as they employ medical imaging systems for proper diagnosis across all patient care settings.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America exhibits a clear dominance in the medical imaging market driven by advancements in AI, increased adoption of advanced imaging technologies, and rising demand for early disease diagnosis.

Recent News and Developments in Medical Imaging Market

  • July 2025: Siemens Healthineers and Prisma Health enhanced their Value Partnership with a $50 million investment in the Ethos adaptive radiotherapy system from Varian. The AI-based treatment planning system adjusts to real-time tumor and anatomy changes, delivering enhanced personalized cancer care while safeguarding healthy tissues across facilities in Tennessee and South Carolina.
  • July 2025: FUJIFILM Healthcare Americas Corporation introduced the FDR Go iQ portable digital radiography solution for hospitals and outpatient surgery centers in the United States. Equipped with touchscreen controls, tube head monitor, and integrated smart charging, the system enables technologists to obtain X-ray room image quality directly at patient bedsides.
  • May 2025: Neuberg Diagnostics established a joint venture with Star Imaging to expand integrated diagnostic centers across Maharashtra, India. The collaboration unites radiology, pathology, wellness, and genomics services within single frameworks, enhancing diagnostic accuracy and speed through comprehensive multi-modal approaches.
  • May 2025: Lunit established a five-year partnership with Starvision Service to deploy multiple medical imaging AI solutions across its 79 locations. Initial deployments include AI-enhanced mammography analysis tools supporting breast cancer screening initiatives in Hamburg, with software for examining chest, breast, and fracture images rolling out across the radiology network.
  • February 2024: Hologic received FDA clearance for the Genius Digital Diagnostics System with Genius Cervical AI algorithm, becoming the first and only FDA-cleared digital cytology system combining deep-learning artificial intelligence with advanced volumetric imaging technology to identify pre-cancerous lesions and cervical cancer cells.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

buyers guide

About the Creator

Michael Richard

Michael Richard is a Market Research Expert specializing in market intelligence, competitive analysis, and data-driven insights. He helps organizations understand trends and emerging opportunities through in-depth research.

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.